Disability following kidney transplantation: The link to medication coverage

Clinical Transplantation

Volumn 21, Issue 2, 2007, Pages 224-228

  Slakey, Douglas P ^a,b,c   Rosner, M ^a  

^a OHIO UNIVERSITY   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disability; Immunosuppressive medication; Insurance; Kidney transplant; Medicare

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISABILITY; EDUCATION; ETHNICITY; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARTTIME EMPLOYMENT; PATIENT ATTITUDE; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; WORK DISABILITY;

ADULT; AGED; ATTITUDE TO HEALTH; DISABLED PERSONS; FEMALE; HUMANS; INSURANCE COVERAGE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RETROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE;

EID: 33947721906     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00629.x     Document Type: Article

References (16)

1. Brown WW. History of the National Kidney Foundation: How end-stage renal disease (ESRD)-Medicare development. Am J Kidney Dis 2000: 35 (Suppl. 1): S3.
2. Anonymous. Americans with Disabilities Act. U.S. Department of Justice. http://www.usdoj.gov/crt/ada.
3. Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res 2005: 14: 1225.
4. Brockow T, Wohlfahrt K, Hillert A et al. Identifying the concepts contained in outcome measures of clinical trials on depressive disorders using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med 2004: 44 (Suppl.): 49.
5. WHO. International Classification of Functioning, Disability and Health. Geneva: World Health Organization, 2001. http://www.3.who.int/icf.
6. Myrtek M, Kaiser A, Rauch B, Jansen G. Factors associated with work resumption: A 5-year follow-up with cardiac patients. Int J Cardiol 1997: 59: 291.
7. White-Williams C, Jalowiec A, Grady K. Who returns to work after heart transplantation? J Heart Lung Transplant 2005: 24: 2255.
8. Wilkins F, Bozik K, Bennett K. The impact of patient education and psychosocial supports on return to normalcy 36 months post-kidney transplant. Clin Transplant 2003: 17 (Suppl. 9): 78.
9. Engle D. Psychosocial aspects of the organ transplant experience: What has been established and what we need for the future. J Clin Psychol 2001: 57: 521.
10. Tawney KW, Tawney PJ, Kovach J. Disablement and rehabilitation in end-stage renal disease. Semin Dial 2003: 16: 447.
11. Thomas C. The Arizona Governor's Rehabilitation Council - removing barriers for the employable disabled. Nephrol News Issues 2004: 18: 42.
12. Kasiske BL, Cohen D, Lucey MR, Neylan JR. Payment for immunosupression after organ transplantation. JAMA 2000: 283: 2445.
13. Yen EF, Hardinger K, Brennan DC et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004: 4: 1703.
14. Woodward RS, Schnitzler MA, Lowell JA et al. Effect of extended coverage of immunosuppressive medications by Medicare on the survival of cadaveric renal transplants. Am J Transplant 2001: 1: 69.
15. Chisholm M, Increasing medication access to transplant recipients. Clin Transplant 2004: 18: 39.
16. Social Security Administration. Ticket to Work and Work Incentive Improvement Act, 1999. http://www.ssa.gov/work.